SDHC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.611600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.442200E-01
Normal-vs-Stage2
3.268600E-01
Normal-vs-Stage3
7.475000E-01
Normal-vs-Stage4
2.127000E-01
Stage1-vs-Stage2
9.284400E-01
Stage1-vs-Stage3
2.273800E-01
Stage1-vs-Stage4
4.533200E-01
Stage2-vs-Stage3
1.321170E-01
Stage2-vs-Stage4
3.692400E-01
Stage3-vs-Stage4
1.484440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.867400E-01
Normal-vs-AfricanAmerican
6.121500E-02
Normal-vs-Asian
5.320200E-01
Caucasian-vs-AfricanAmerican
1.271200E-01
Caucasian-vs-Asian
8.763400E-01
AfricanAmerican-vs-Asian
3.751200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.717400E-01
Normal-vs-Female
3.570000E-01
Male-vs-Female
9.787000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.470600E-01
Normal-vs-Age(41-60Yrs)
2.529000E-01
Normal-vs-Age(61-80Yrs)
4.393400E-01
Normal-vs-Age(81-100Yrs)
1.184410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.874200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.765800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.756650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.653600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.334200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.838400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.476200E-01
Normal-vs-Daily Drinker
8.421600E-01
Normal-vs-Weekly Drinker
4.266600E-01
Normal-vs-Occasional Drinker
8.699500E-02
Normal-vs-Social Drinker
3.566200E-01
Non Drinker-vs-Daily Drinker
1.861210E-01
Non Drinker-vs-Weekly Drinker
8.779400E-01
Non Drinker-vs-Occasional Drinker
1.443030E-01
Non Drinker-vs-Social Drinker
8.310800E-01
Daily Drinker-vs-Weekly Drinker
2.043400E-01
Daily Drinker-vs-Occasional Drinker
5.464600E-03
Daily Drinker-vs-Social Drinker
1.567040E-01
Weekly Drinker-vs-Occasional Drinker
2.694000E-01
Weekly Drinker-vs-Social Drinker
9.658800E-01
Occasional Drinker-vs-Social Drinker
2.520000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.989600E-01
Normal-vs-Grade 2
9.264000E-02
Normal-vs-Grade 3
8.523800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.785900E-02
Grade 1-vs-Grade 3
5.805500E-02
Grade 1-vs-Grade 4
2.989600E-01
Grade 2-vs-Grade 3
9.575600E-01
Grade 2-vs-Grade 4
9.264000E-02
Grade 3-vs-Grade 4
8.523800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.562800E-01
Normal-vs-NonDiabetic
3.489600E-01
Diabetic-vs-NonDiabetic
4.569400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.703600E-01
Normal-vs-NoPancreatitis
4.015800E-01
Pancreatitis-vs-NoPancreatitis
9.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.558200E-01
Normal-vs-N1
3.745600E-01
N0-vs-N1
3.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.400180E-01
Normal-vs-TP53-NonMutant
4.472400E-01
TP53-Mutant-vs-TP53-NonMutant
5.347600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
